Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The global population at risk from mosquito-borne diseases - including yellow fever, Zika and dengue - is expanding with changes in the distribution of two key mosquitoes: Aedes aegypti and Aedes albopictus. The spread of these species is largely driven by a combination of factors: human movements and climate change.

Swarm of mosquitoes © Shutterstock

Now, with an unprecedented level of accuracy, an international team of researchers, led by Dr Moritz Kramer at the University of Oxford’s Department of Zoology, have used statistical mapping techniques to predict where the species will spread over an immediate, medium and long-term time-scale. Published in Nature Microbiology they pinpoint this information with the precision of 5x5 km.

The researchers have used 35 years of historic data, together with 17 of the highest-regarded and accepted climate change models to create a tool for public health officials which will allow them to target resource most efficiently and effectively to combat disease outbreak.

Read more (University of Oxford website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.